Abstract
Amplatzer Atrial Septal Occluder device has been routinely and successfully used as a percutaneous alternative to cardiac surgery for closure of atrial septal defects. It has shown to the safe with a low complication profile. Complications that most commonly occur with atrial septal defect (ASD) closure devices include malposition or embolization, residual shunt, atrial arrhythmias, thrombosis over the vena cava or atrium, erosion and perforation of the heart, and infective endocarditis. The most common complications associated with an ASD occluder device appear to be embolization and malposition with embolization usually occurring in the main pulmonary artery. We present a case in which the ASO device, AmplatzerTM (Abbott, USA), embolized into the left ventricle.
Highlights
Atrial septal defect (ASD) is one of the most common congenital cardiac malformations [1,2,3]
We present a patient with a large ASD who had an episode of emesis following an AmplatzerTM (Abbott, USA) closure device placement, which likely led to embolization of the device across the atrial septum and into the left ventricle
A 55-year-old female with a past medical history of hypertension initially presented to the hospital with shortness of breath and found to be in a new-onset atrial flutter with 2:1 block and a ventricular rate of 140 beats per minute. She was admitted for rate control and underwent a transesophageal echo (TEE) to evaluate a pansystolic 3/6 murmur best heard over the third intercostal space on the left
Summary
Atrial septal defect (ASD) is one of the most common congenital cardiac malformations [1,2,3]. We present a patient with a large ASD who had an episode of emesis following an AmplatzerTM (Abbott, USA) closure device placement, which likely led to embolization of the device across the atrial septum and into the left ventricle. A 55-year-old female with a past medical history of hypertension initially presented to the hospital with shortness of breath and found to be in a new-onset atrial flutter with 2:1 block and a ventricular rate of 140 beats per minute She was admitted for rate control and underwent a transesophageal echo (TEE) to evaluate a pansystolic 3/6 murmur best heard over the third intercostal space on the left. She was evaluated by the structural heart team and later posted for ASD closure in the interventional suite. Transthoracic echo on the day following the procedure showed that the device was still in place across the atrial septum with no residual leak
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
